AI/ML Innovations — Investor Presentation (February 2024)
24 slides from AI/ML Innovations's investor presentation, Feb 14, 2024

Slide 1: Revolutionizing Healthcare: The Future of Wearables, AI, and Remote Patient Monitoring
CSE: AIML OTCQB: AIMLF FWB: 42FB Health Paul Duffy || CEO Intelligence Revolutionizing Healthcare: The Future of Wearables, AI, and Remote Patient Monitoring Enabling Healthier Futures February 14th, 2024

Slide 2: Forward Looking Statement
Forward Looking Statement This presentation may contain forward-looking statements that involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of AI/ML Innovations Inc., or industry results to be materially different from an

Slide 3: Town Hall Agenda
Enabling Healthier Futures TOWN HALL AGENDA ● What we Do ● The Next 90 Days ● Milestones & Updates ● Questions & Answers

Slide 4: The AI/ML Biometric Journey
The AI/ML Biometric Journey Capture Smart Sensor Wearables Capture biometric signals or pulses through our “Pulse Whisperer” API’s, Connectors, SDK For Time-Series Data Collection Analyze Analyze using our proprietary and patented Neural Networks, Machine Learning, and Artificial Intelligence servic

Slide 5: Non-invasive AI/ML Blood Pressure
2023 Innovation Grand Prize at the prestigious L'Encéphale Medical Congress in Paris Non-invasive AI/ML Blood Pressure

Slide 6: The First 100 Days: Milestones Q4, CY 2023
The First 100 Days: Milestones Q4, CY 2023 One: Book $1.0MM in orders for 2024 ● Health Gauge Inc. (95.2% owned by AIML) ○ In North America, renews approximately $300K CDN ○ Professional Services & License Agreement of the Health Gauge Platform and Neural Net ● Tech2Heal (up to 22% ownership rights,

Slide 7: Sales are Starting
Sales are Starting From Pitch to Purchase Traction in the First 100 Days: ● AI and Remote Patient Monitoring for Blood Pressure Management ● AI Licensing for Patented Neural Net ● Clinical Trial Management Systems ● University Hospital of Nice Aging Well Clinical Study - 2 Trials Underway ● Europe’s

Slide 8: Aging Well
Aging Well CLINICAL TRIAL HIGHLIGHTS Personalized program for preventing loss of autonomy in the elderly: Key Metrics - Accessibility, Empowerment, and Environmental Adaptations The CHU is launching the biggest decentralized clinical trial in order to prevent loss of autonomy in the elderly. With a

Slide 9: My Health Friend
My Health Friend Funded by a European Commission Fund ● Multi-language Health App for Cross-Border Populations (French, Italian, English) - Personalized Digital Rehabilitation to Prevent Chronic Diseases, Reduce Socio-Health Impact. Objective 1 - Setup and Data Collection ● Target Study: General pop

Slide 10: Prescription for Growth: Investing in the Clinical Trials Boom
Prescription for Growth: Investing in the Clinical Trials Boom The global clinical trial management system market size was estimated at USD 1.6 billion in 2022 and it is expected to reach around USD 5.22 billion by 2032, poised to grow at a compound annual growth rate (CAGR) of 12.6% during the fore

Slide 11: The Next 90 Days: Milestones Q1, CY 2024
The Next 90 Days: Milestones Q1, CY 2024 One: Build Funnel, Create Pipeline ● Jan 15th - Launch of the Health Gauge Biometrics website ○ Aligned to Product / Market Fit with SEO/SEM for Lead Gen ● Secure Pilot Programs and New Accounts Two: Build Products ● Jan 31st - Launch of v1.0 of The Pulse Whi

Slide 12: Biometrics Unleashed: Welcome to Health Tech 2.0
& Biometrics Unleashed Welcome to Health Tech 2.0 The Era of Health Intelligence At the dawn of 2024, advancements in Artificial Intelligence (Al). Predictive Analytics (PA), Large Language Models (LLM) and Transformers (GPT) have reset everything to a new normal. Scroll to Dream ¢ HealthGauge Home

Slide 13: The Pulse Whisperer v1.0 Launch
es eX HealthGauge Home Products v Solutions Learn About Us { Support Monday 7h 40m oy = V1.0 LAUNCHING JANUARY 31, 2024 Need Biometric Raw Signal Data?

Slide 14: Follow Your Heart v1.0 Launch
<> eS HealthGauge Home Products Solutions Learn = About Us Moen Support ® °.@ e A ay ry V1.0 LAUNCHING FEBRUARY 29, 2024 Follow Your Heart Non Invasive Blood Pressure Measuremerit & Monitoring 7 Edit site

Slide 15: Care pathway platform screenshot
o* *#O@: Cardiac cS 109/73 36 a 2 ® HealthCare Solutions, Inc > Healthcare Worker | Dr. Ryan Mitchell s) BP HRV (RMSSD) h ECG v A Se Setup 7 | 83 122/75 22 = HR (bpm) BP (mmhg) HRV & Survey &% Groups PPG vA & Rules 30k 5 Calendar Care People hat wach ECG Peaks Ee meet.google.com is sharing your scre

Slide 16: Non-Invasive Blood Pressure Product
Non-Invasive Blood Pressure Product Unit Price $249.99 Heart Disease Impact Fact - Blood pressure measurement is a key diagnostic and preventive 100 MILLION tool in the context of heart disease PEOPLE AFFECTED IN NORTH AMERICA 1.5 BILLION Percentage Units Revenue PEOPLE AFFECTED WORLDWIDE 0.05% 50,0

Slide 17: Neural Nets: Training & FDA
Neural Nets: Training & FDA Why are we doing all this? ● Biometric Smart Sensors need Neural Nets to convert Signals & Pulses to precise measurements. ○ Transforming millions of inputs into actionable insights through our innovative biometric InfoPulse. (more on this in our Next 100 Days) ● Advance

Slide 18: mmHG - Millimeters of Mercury
* mmHG - Millimeters of Mercury

Slide 19: mmHG - Millimeters of Mercury
* mmHG - Millimeters of Mercury

Slide 20: Health Gauge Regulatory: Current NN Solution Version 1.0
HEALTH GAUGE REGULATORY: Current NN Solution: Version 1.0 Model _... as of February 12, 2024 HG SYSTOLIC Blood Pressure DIASTOLIC Blood Pressure ara SYS (ST-Dev) MEAN AVG DIA (ST-Dev) | _ MEAN AVG Note: The ST-DEV numbers and MAD mmHg Deviation (MAD) mmHg Deviation (MAD) numbers are getting lower. D

Slide 21: 132/78
132/78

Slide 22: Health Gauge Biometrics Platform for Life Sciences
Health Gauge Biometrics Platform for Life Sciences Unleash your Quantified Self Improve your health through an incremental and data- informed approach. Learn more le gat BloodPressure —g4syS_S6DIA Weedy verege Heart rate Todey Week Month Year 180 40 Daily Lowest Resting HR 122.SyS Welty average

Slide 23: Health Gauge V2.0 Launching March 31, 2024
8B HealthGauge ae V2.0 LAUNCHING MARCH 31, 2024 Biometric Magic Prioritize Your Well-being: Where Continuous Monitoring, Precision, Privacy, and Hedith take Center Stage Support

Slide 24: Questions & Answers
Questions & Answers Revolutionizing Healthcare: The Future of Wearables, AI, and Remote Patient Monitoring Enabling Healthier Futures
Source: Internet Archive copy of aiml-innovations.com

